5 research outputs found
Proteinuria and Albuminuria at Point of Care
Proteinuria is a key diagnostic and pathophysiological aspect of kidney dysfunction, influencing the progression of kidney and systemic diseases. Both general practitioners and specialists should be able to discriminate the relevance of proteinuria, starting from a urine sample, and eventually referring selected patients to a nephrologist for further diagnostic workup and treatment, because most kidney diseases are not symptomatic until renal function is lost or severely compromised. As the interpretation of proteinuria is dependent on the method used to detect it, the aim of this article was to review laboratory and point-of-care diagnostic methods for proteinuria in different settings, such as the prevention and follow-up of common chronic diseases (i.e., hypertension, diabetes, chronic kidney disease). Urine dipsticks remain the most widely used method for detecting proteinuria, although different types of proteinuria, extreme pH values and urine concentration may affect their results. Albumin to creatinine ratio and protein to creatinine ratio performed on a spot urine sample are reliable tests that can effectively replace 24-hour urine collection analysis in clinical practice
Recommended from our members
Recommendations on data sharing in HIV drug resistance research
Acknowledgements: The findings and conclusions in this manuscript are those of the authors and do not necessarily represent the official position of the United States Centers for Disease Control and Prevention or any other institutions.Author summary: • Human immunodeficiency virus (HIV) drug resistance has implications for antiretroviral treatment strategies and for containing the HIV pandemic because the development of HIV drug resistance leads to the requirement for antiretroviral drugs that may be less effective, less well-tolerated, and more expensive than those used in first-line regimens. • HIV drug resistance studies are designed to determine which HIV mutations are selected by antiretroviral drugs and, in turn, how these mutations affect antiretroviral drug susceptibility and response to future antiretroviral treatment regimens. • Such studies collectively form a vital knowledge base essential for monitoring global HIV drug resistance trends, interpreting HIV genotypic tests, and updating HIV treatment guidelines. • Although HIV drug resistance data are collected in many studies, such data are often not publicly shared, prompting the need to recommend best practices to encourage and standardize HIV drug resistance data sharing. • In contrast to other viruses, sharing HIV sequences from phylogenetic studies of transmission dynamics requires additional precautions as HIV transmission is criminalized in many countries and regions. • Our recommendations are designed to ensure that the data that contribute to HIV drug resistance knowledge will be available without undue hardship to those publishing HIV drug resistance studies and without risk to people living with HIV